Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Tóm tắt
Từ khóa
Tài liệu tham khảo
Liu, 2020, Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV, Chembiochem, 21, 730, 10.1002/cbic.202000047
W, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, 30, 269, 10.1038/s41422-020-0282-0
L, 2020, [Potential antiviral therapeutics for 2019 novel coronavirus]., Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chin J Tubercul Respir Dis, 43, E2
Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017
Chen, 2020, Emerging coronaviruses: genome structure, replication, and pathogenesis, J Med Virol, 92, 418, 10.1002/jmv.25681
Du, 2009, The spike protein of SARS-CoV — a target for vaccine and therapeutic development, Nat Rev Microbiol, 7, 226, 10.1038/nrmicro2090
Zhou, 2020, 2020
Qiu, 2020, Identification of potential cross-protective epitope between 2019-nCoV and SARS virus, J Genet Genom, S1673
Hoffmann, 2020, 2020
Xu, 2020, Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission, Sci China Life Sci, 63, 457, 10.1007/s11427-020-1637-5
Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7
Wrapp, 2020, 2020
Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet (London, England), 395, 497, 10.1016/S0140-6736(20)30183-5
Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet (London, England), 395, 514, 10.1016/S0140-6736(20)30154-9
Fan, 2020, 2020
Zhang, 2020, 2020
Wong, 2004, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin Exp Immunol, 136, 95, 10.1111/j.1365-2249.2004.02415.x
Mahallawi, 2018, MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile, Cytokine, 104, 8, 10.1016/j.cyto.2018.01.025
Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, The Lancet Respir Med, S2213
Zou, 2020, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, N Engl J Med, 382, 1177, 10.1056/NEJMc2001737
L, 2019, Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge, Sci Transl Med, 11
Cj, 2020, The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus, J Biol Chem
Tp, 2020, Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV., Nat Commun, 11, 222, 10.1038/s41467-019-13940-6
de Wit, 2020, Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection, Proc Natl Acad Sci U S A, 117, 6771, 10.1073/pnas.1922083117
Warren, 2015, Nucleotide prodrug GS-5734 is a broad-spectrum filovirus inhibitor that provides complete therapeutic protection against the development of Ebola virus disease (EVD) in infected non-human primates, 139, 311
Appendix 4, 2018
M, 2019, A randomized, controlled trial of Ebola virus disease therapeutics, The New England journal of medicine, 381, 2293, 10.1056/NEJMoa1910993
B, 2017, The pathogenesis of Ebola virus disease, Annual review of pathology, 12, 387, 10.1146/annurev-pathol-052016-100506
W, 2016, Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys, Nature, 531, 381, 10.1038/nature17180
Jordan, 2018, Nucleosides for the treatment of respiratory RNA virus infections, Antivir Chem Chemother, 26, 10.1177/2040206618764483
Kim, 2020, The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures, J Kor Med Sci, 35, e61, 10.3346/jkms.2020.35.e61
Chen, 2020, COVID-19 control in China during mass population movements at New Year, Lancet, 395, 764, 10.1016/S0140-6736(20)30421-9
A, 2020, Remdesivir as a possible therapeutic option for the COVID-19., Trav Med Infect Dis
Pedersen, 2019, Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis, J Feline Med Surg, 21, 271, 10.1177/1098612X19825701
Ml, 2018, Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease, mBio, 9